The Parenteral Drug Association will kick off its annual conference on Pharmaceutical Microbiology on October 10, followed by the 2022 PDA Rapid Microbiological Methods Workshop on October 12.

Since 2017, Cell & Gene Therapy World Asia has witnessed huge success in bringing over 300 industry pioneers from both cell & gene therapy industry. With the mission to facilitate the research & development and manufacturing of high quality cell & gene therapy treatments and regenerative medicines in Asia, Cell & Gene Therapy World Asia is going to continue its legacy.

The ISPE Singapore Affiliate Conference & Exhibition is one of the largest and most respected pharmaceutical manufacturing shows in Singapore for pharmaceutical and biomanufacturing professionals. The annual event highlights the best practices and services - from manufacturing facility design to the finished product.

An international community of professionals sharing knowledge to enhance transfusion practice.

The ISCT Annual Meeting is the largest global forum connecting cell and gene therapy translation professionals to educate, inspire, network and collaborate. ISCT 2022 will draw from international experts across industry, academic and regulatory spheres with the purpose of building consensus to drive the field forward. With a program driven by world-class leaders, the ISCT Annual Meeting is a truly unique platform that addresses the biggest bottlenecks in cell and gene therapy development.

This Conference will focus on the theme to Level Up: Agility in the New Normal! We will highlight what’s in store for the future of pharmaceutical manufacturing. Examine how companies are developing new modalities and adapting to the current manufacturing environment through the modernization of aging facilities and the adoption of innovative approaches and processes.

Learn how to improve process efficiencies and maintain product quality across all phases of bioprocessing. The BPI US West 2022 scientific agenda covers today's latest innovations across all phases of biopharmaceutical development and manufacturing.

Engage with our experts as they discuss their research regarding mycoplasma detection, microbial sugars as LAL reactive substances, and a comparative performance study of adjusted BACT/ALERT® iFA Plus for growth promotion and antimicrobial neutralization.

During this bioworkshop, Guillaume Charmier (Product HSE Specialist) & Sonja Novak (Healthcare Product Manager) will share this regulatory approach with you and present you how bioMérieux anticipates and integrates regulatory changes in the development of its solutions.

This summit will explore, define and attempt to tackle the challenges to development of patient access to ATMPs, and how we move forward into a brighter 2022.

bioMerieux is pleased to invite you to attend the upcoming PharmaTechnica Congress. From 20 – 22 April 2021 the PharmaTechnica congress will take place virtually for the second time. During the congress, we will have the pleasure to present the following session: Bioproduction & ATMPs: How to Better Drive your Performance & Productivity with Better Process and Microbiological Control